Tempus AI Inc. has announced a new collaboration with Northwestern University's Abrams Research Center on Neurogenomics to advance research in Alzheimer's disease. The multi-year partnership will utilize Tempus' AI-powered data analytics platform, Lens, to analyze genomic data and uncover patterns that may enhance the understanding of Alzheimer's. The collaboration aims to develop new therapeutics and clinical applications, driving the discovery of targeted therapies to improve patient outcomes. There is no mention of whether the results of this collaboration have been presented or are scheduled to be presented in the future.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempus AI Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250611148764) on June 12, 2025, and is solely responsible for the information contained therein.
Comments